Home/Filings/4/0001415889-24-017677
4//SEC Filing

Svoronos Dawn 4

Accession 0001415889-24-017677

CIK 0001501756other

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 4:47 PM ET

Size

12.3 KB

Accession

0001415889-24-017677

Insider Transaction Report

Form 4
Period: 2024-06-17
Graham Dawn
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-17+10,52010,520 total
    Exercise: $7.32Exp: 2034-06-16Common Stock (10,520 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest and become exercisable on the earlier of June 17, 2025 or the 2025 annual meeting of stockholders, subject to (1) accelerated vesting upon a change of control and (2) the Reporting Person's continued service with the Issuer on the vesting date.

Issuer

Adverum Biotechnologies, Inc.

CIK 0001501756

Entity typeother

Related Parties

1
  • filerCIK 0001574579

Filing Metadata

Form type
4
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:47 PM ET
Size
12.3 KB